Written by Hazel Norman on November 21, 2022. Posted in Business, Entertainment, Policy.

A common misconception about cannabis reform is that once a jurisdiction’s lawmakers or voters initially approve an adult-use legalization measure, that there’s nothing left to do. In reality, that couldn’t be farther from the truth. The fact of the matter is that the push for reform continues well after a successful legalization vote. The effort behind pushing for sensible cannabis policies doesn’t change. Only the direction of where that effort is focused changes.

Immediately after an adult-use cannabis legalization measure is initially passed, the focus then shifts to more nuanced and granular aspects of cannabis policy. In the instances in which a jurisdiction’s legalization model permits legal sales, making sure that sensible regulations are adopted is extremely vital. One area of cannabis commerce that seems to often be overlooked, or at least is not properly embraced by governments, is cannabis tourism.

More Than Just Clubs And Lounges

Typically, when people think of cannabis-based tourism they think of coffeeshops, clubs, and lounges. While those are certainly valid examples of cannabis tourism, the sector of the emerging cannabis industry is much more complex these days, and evolving constantly. People still travel to Amsterdam to frequent the city’s historic coffeeshops, however, people now have far more options, and those options create additional opportunities for entrepreneurs and innovators.

Canada is home to the only nationwide, legal adult-use cannabis industry that is open to anyone of legal age. Uruguay also permits legal adult-use sales, however, they are limited to residents only. Malta passed an adult-use legalization measure late last year, and eventually the country will have cannabis clubs. However, no legal clubs are currently in operation.

Being that it’s a legal oasis to the world in many ways, Canada is a top international cannabis tourism destination. Consumption in public is still prohibited, so social use establishments like lounges play a vital role. Canada is home to a growing number of cannabis-friendly lodging choices, industry tours, and other ancillary cannabis tourism businesses, many of which do not ‘touch the plant’ directly.

A Growing Opportunity Cost

Some parts of the world are already established as top cannabis tourism destinations. It doesn’t take a cannabis historian to name some of them – The Netherlands, Spain, Jamaica, etc. For reasons that don’t quite make sense, very few of the current high-profile destinations seem to embrace cannabis tourism. That seeming lack of enthusiasm for cannabis tourism creates opportunities for other countries that want to fill the void.

For example, leaders in the Czech Republic have indicated that they want to follow Germany’s lead in passing an adult-use legalization measure, with a specific interest in becoming a cannabis tourism destination given the fact that current legalization plans in Germany do not appear to include cannabis clubs at this time.

“They do not have cannabis clubs that we are supposed to. I’m pretty sure I want to hold on to cannabis clubs until my last breath.” stated national anti-drug coordinator for the Czech Republic, Jindřich Vobořil in a post on his Facebook page.

People are going to travel to far off places for, among other things, cannabis experiences. This will be true even where cannabis remains illegal. Given that every country on earth needs increased public revenue, job creation, and boosts to local economies, cannabis tourism should be embraced by governments and not shunned. Any concerns about the sky falling if/when social use is permitted in a given jurisdiction are overblown, and the only people that claim otherwise are likely profiting directly off of prohibition.

In many ways the United States has historically served as ground zero for the war on cannabis. The U.S. is not the only country to prohibit cannabis at the national level, however, decades ago it largely led the charge in support of cannabis prohibition and wielded its international influence to make sure that prohibition became the law of the planet.

In recent decades the frost of cannabis prohibition in the U.S. has steadily started to thaw, particularly after Colorado and Washington State became the first in the nation to pass adult-use legalization measures in 2012 and subsequently launched adult-use sales in 2014.

Zoom forward to today and there are now 21 states that have passed adult-use legalization measures, in addition to Washington D.C. Gallup recently released its annual cannabis legalization poll results, and support remained at a record high of 68%. As I often point out, you will be hard pressed to find any other political issue in the U.S. right now that has that level of support.

Yet, despite that backdrop and growing momentum, cannabis reform within the United States Congress has lagged considerably. Various bills have come and gone over the years, with some seeing limited success in one chamber but not the other. That changed recently when both chambers of the U.S. Congress finally passed a stand-alone cannabis bill, with the bill currently awaiting the U.S. President’s signature.

The bill is called the “Medical Marijuana and Cannabidiol Research Expansion Act” and it would boost cannabis research efforts in the U.S. The legislation, which was originally introduced in July with bipartisan support,  passed the House prior to successfully making its way through the Senate.

“After working on the issue of cannabis reform for decades, finally the dam is starting to break. The passage of my Medical Marijuana and Cannabidiol Research Expansion Act in the House and Senate represents a historic breakthrough in addressing the federal government’s failed and misguided prohibition of cannabis.” stated Congressman Earl Blumenauer, who co-introduced the legislation in the House. Congressman Blumenauer has previously spoken at International Cannabis Business Conference events.

“As we have seen in state after state, the public is tired of waiting for the federal government to catch up. Nearly half of our nation’s population now live in states where adult-use of cannabis is legal. For far too long, Congress has stood in the way of science and progress, creating barriers for researchers attempting to study cannabis and its benefits. At a time when more than 155 million Americans reside where adult-use of cannabis is legal at the state or local level and there are four million registered medical marijuana users with many more likely to self-medicate, it is essential that we are able to fully study the impacts of cannabis use.” Congressman Blumenauer went on to say.

“The passage of this legislation coming just weeks after the change in President Biden’s posture towards cannabis is extraordinarily significant. We must capitalize on this momentum to move subsequent common-sense House-passed bills like the SAFE Banking Act, which finally allows state-legal dispensaries to access banking services and reduce their risk of violent robberies.” Congressman Blumenauer concluded.

Written by Hazel Norman on November 14, 2022. Posted in Business, Policy.

Cannabis reform may be spreading across the globe at an ever-increasing pace, and with it, the emerging international cannabis industry, however, the process has moved slower in some countries compared to others, with Costa Rica being a great example of that.

In the Western Hemisphere, cannabis reform has spread faster than its Eastern Hemisphere counterpart. After all, Uruguay was the first nation to legalize cannabis for adult-use, followed by Canada becoming the first G-7 nation to do so. Significant cannabis reform can be found elsewhere in the hemisphere as well.

Yet, cannabis policy reform and standing up a regulated industry has proceeded at a slower rate in Costa Rica. As we previously reported, lawmakers in Costa Rica passed a cannabis reform measure in 2021 and sent it to the President for sign off. That sign off never occurred, and instead, Costa Rica’s president issued a veto and sent the measure back to lawmakers instructing them to make the measure more strict.

Eventually things moved along a bit, and finally, after a lot of political wrangling and foot dragging, Costa Rica has issued its first hemp project license. Per The Tico Times:

The Minister of Agriculture and Livestock (MAG), Víctor Julio Carvajal Porras, signed the resolution authorizing the first project for the use of hemp this Friday.

Ingenio Taboga S.A. made the request. It is located in Bebedero de Cañas, Guanacaste, developing a hemp cultivation and processing project in a 150-hectare area.

According to the reporting by The Tico Times, there are eight more industry applications being considered – seven for hemp-related projects, and one for medical cannabis. It’s unclear if/when any of those additional projects will gain approval.

According to Statista, Costa Rica’s gross domestic product (GDP) ranked 11th in 2021 out of countries located in the Latin America and Caribbean regions. Any jobs and economic boost that the cannabis industry can provide Costa Rica is surely welcomed.

Written by Frank Schuler on November 14, 2022. Posted in Science.

Cannabidiol (CBD) is arguably the most popular cannabinoid on planet earth right now. As proof of that, consider the fact that according to Google trends ‘CBD’ was searched for by platform users more than twice as often as ‘THC’ over the course of the last year.

Of course, THC remains extremely popular both as a search topic and as a consumable. However, CBD is often seen as the more favorable cannabinoid between the two from the perspective of lawmakers and researchers, as demonstrated by the growing availability of legal CBD products around the globe and the increasing number of CBD-focused research projects being funded.

A recent study in Canada examined CBD-dominant extracts that were plant derived and their potential effects on autism as part of a case study. Below is more information about it via a news release from NORML:

Toronto, Canada: The twice-daily administration of plant-derived CBD-dominant extracts is “an effective treatment for managing symptoms associated with autism,” according to a case report published in the journal Cureus.

A team of Canadian investigators documented the treatment of a nine-year old patient diagnosed with nonverbal autism spectrum disorder (ASD). The patient received twice-daily dosing of a high-CBD/low-THC extract oil.

Researchers reported, “The child patient responded positively to the introduction of CBD oil treatment with reduced negative behaviors, better sleep, and improved communication.” No adverse side-effects were reported.

They concluded, “With the increasing clinical studies on the use of cannabidiol in treating patients with mood disorders, anxiety, chronic pain conditions, and other behavioral problems, it should be considered as a treatment option in managing symptoms related to autism.”

The findings are consistent with several other studies similarly reporting improvements in pediatric patients’ ASD symptoms following the use of cannabinoid products, particularly CBD-rich extracts. Survey data published in 2021 by the publication Autism Parenting Magazine reported that 22 percent of US caregivers or parents have provided CBD to an autistic child. Survey data from the United Kingdom recently reported that autistic adults were nearly four times as likely as controls to report having used CBD within the past year.

Full text of the study, “Cannabidiol in the treatment of autism spectrum disorder: A case study,” appears in Cureus. Additional information on cannabis and ASD is available from NORML.

Written by Frank Schuler on November 14, 2022. Posted in Science.

When it comes to medical cannabis, inhaled consumption methods can be seen as controversial within certain medical and political circles. After all, so much effort has been spent encouraging people to not smoke tobacco cigarettes, and many people see the two products as being one and the same. However, tobacco and cannabis are not the same thing, and studies demonstrate that.

Many lawmakers around the globe seem to be hesitant to legalize medical cannabis in forms that involve inhalation, which is unfortunate. For many suffering patients, inhaling cannabis is the cheapest and easiest way to consume their medicine, and given that inhaled cannabis interacts with the human body quicker compared to ingested cannabis, many patients prefer it for one reason or another.

Suffering patients should be able to consume cannabis in any manner that helps them, including inhaling it. A recent study from the United Kingdom found that inhaled cannabis may help treat pain and anxiety. Below is more information about it via a news release from NORML:

London, United Kingdom: The sustained vaporization of THC-dominant cannabis flowers improves health-related quality of life measurements in patients suffering from chronic pain and anxiety-related disorders, according to observational data published in the journal Biomedicines.

A team of British and Spanish investigators assessed cannabis’ efficacy in a cohort of 451 British patients authorized to consume cannabis flowers for treatment-resistant pain and/or anxiety. Patients in the study were all enrolled with Project Twenty21, “the first U.K. multi-center registry seeking to develop a body of real-world evidence to inform on the effectiveness and safety of medical cannabis.” All of the study’s participants had failed to respond to at least two prescription treatment options prior to obtaining an authorization for medical cannabis. All participants vaporized cannabis flowers for a period of at least three months.

Researchers reported that cannabis inhalation was associated with sustained (6+ months) improvements in both patient populations and that side effects were “minimal.” Investigators reported more significant improvements among those diagnosed with treatment-resistant anxiety.

“Our results indicate that controlled inhalation of pharmaceutical grade, THC-predominant cannabis flos [flowers] is associated with a significant improvement in patient-reported pain scores, mood, anxiety, sleep disturbances and overall HRQoL [health-related quality of life] in a treatment-resistant clinical population,” authors concluded.

Numerous surveys indicate that patients most frequently self-report using cannabis to mitigate symptoms of pain and anxiety.

Full text of the study, “Controlled inhalation of THC-predominant cannabis flos (flowers for inhalation) improves health-related quality of life and symptoms of pain and anxiety in eligible UK patients,” appears in Biomedicines.